Breaking News Instant updates and real-time market news.

BIIB

Biogen

$292.64

0.17 (0.06%)

, UAL

United Continental

$67.23

-0.94 (-1.38%)

10:41
03/16/17
03/16
10:41
03/16/17
10:41

On The Fly: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Biogen (BIIB) was downgraded to Equal Weight from Overweight at Morgan Stanley and Market Perform from Outperform at Leerink. 2. United Continental (UAL) downgraded to In Line from Outperform at Evercore ISI. 3. Tyson Foods (TSN) downgraded to Hold from Buy at Argus with analyst John Staszak citing the SEC probe of Tyson and other poultry producers, potential decelerating earnings in coming quarters, and a recent bird flu outbreak in two states. 4. Williams-Sonoma (WSM) downgraded to Market Perform from Outperform at William Blair with analyst Daniel Hofkin citing the company's fourth quarter results. 5. Inovio (INO) downgraded to Neutral from Overweight at Piper Jaffray with analyst Charles Duncan saying a "lack of focus and advancement for any one program" poses execution risk to the broader platform, and to shareholders. The analyst lowered his price target for the shares to $9 from $13 following the company's Q4 results. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

BIIB

Biogen

$292.64

0.17 (0.06%)

UAL

United Continental

$67.23

-0.94 (-1.38%)

TSN

Tyson Foods

$62.08

-1.02 (-1.62%)

WSM

Williams-Sonoma

$49.47

1.35 (2.81%)

INO

Inovio

$6.87

0.26 (3.93%)

  • 19

    Mar

  • 20

    Mar

  • 20

    Jun

BIIB Biogen
$292.64

0.17 (0.06%)

03/16/17
MSCO
03/16/17
DOWNGRADE
Target $305
MSCO
Equal Weight
Biogen downgraded to Equal Weight from Overweight at Morgan Stanley
Morgan Stanley analyst Matthew Harrison downgraded Biogen to Equal Weight and lowered his price target for the shares to $305 from $369.
03/16/17
03/16/17
DOWNGRADE
Target $300

Market Perform
Biogen downgraded to Market Perform at Leerink
As previously reported, Leerink analyst Geoffrey Porges downgraded Biogen to Market Perform from Outperform based on a slower than expected ramp for Spinraza, and the completion of the series of important catalysts that have evolved over the last few months. The analyst is not particularly positive about the other programs in Biogen's late stage pipeline such as BIIB074, BIIB059, STX100 and opicinumab. Porges also lowered his price target on the shares to $300 from $305.
03/16/17
03/16/17
DOWNGRADE

Equal Weight
Biogen cut to Equal Weight as Alzheimer's data awaited at Morgan Stanley
As previously reported, Morgan Stanley analyst Matthew Harrison downgraded Biogen to Equal Weight from Overweight and lowered his price target for the shares to $305 from $369, saying that he sees limited upside for the stock in the near-term. The analyst said his rating change was "not a downside call, but a timing call" as he continues to have a positive view of Alzheimer's candidate aducanumab, though its data is not due until the second half of 2019. In arriving at his $305 price target, Harrison attributes $235 for the base business and $70 per share for aducanumab.
03/16/17
LEER
03/16/17
DOWNGRADE
Target $300
LEER
Market Perform
Biogen downgraded to Market Perform from Outperform at Leerink
UAL United Continental
$67.23

-0.94 (-1.38%)

03/13/17
UBSW
03/13/17
NO CHANGE
UBSW
Buy
Weakness in airline sector a buying opportunity, says UBS
UBS analyst Darryl Genovisi said the recent dip in airline shares provides a buying opportunity. The analyst noted most of the airlines have cut their PRASM guidance for Q1 and with the miss already priced in and a better outlook for Q2, investors should be buyers of the group. Genovisi prefers United Continental (UAL) followed by Delta (DAL) and Southwest (LUV).
03/16/17
EVER
03/16/17
DOWNGRADE
EVER
In Line
United Continental downgraded to In Line from Outperform at Evercore ISI
Evercore ISI analyst Duane Pfennigwerth downgraded United Continental to In Line.
02/22/17
02/22/17
NO CHANGE

Morgan Stanley would not dismiss possibility of Berkshire buying an airline
With Warren Buffett's Berkshire Hathaway (BRK.A) recently disclosing an increase to its overall airline exposure, making the firm a number one or two holder for each of the "Big 4," Morgan Stanley polled investors and found that about 60% do not expect this to be a step towards a full-scale acquisition. However, analyst Rajeev Lalwani said the prospect of Berkshire buying an airline is a possibility that is "not worth dismissing," citing the historical precedent of Buffett's involvement in the rail industry and eventual deal to buy Burlington Northern SantaFe in 2009. The top four U.S. airlines include American Airlines (AAL), Delta Air Lines (DAL), Southwest (LUV) and United Continental (UAL).
01/05/17
01/05/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Macy's (M) downgraded to Hold from Buy at Deutsche Bank with analyst Paul Trussell saying the company's turnaround initiatives "continue to fall short of expectations." The "discouraging" 2017 forecast reflects the "realities of market share losses" to off-price retail, Amazon (AMZN) and other online threats, Trussell tells investors in a research note after Macy's lowered its outlook. He cut his price target for the shares to $34 from $47. 2. Kohl's (KSS) downgraded to Market Perform from Outperform at Telsey Advisory and to Neutral from Outperform at Baird. 3. DCP Midstream (DPM) downgraded to Sector Perform from Outperform at RBC Capital and to Underperform from Neutral at Credit Suisse. 4. United Continental (UAL) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Rajeev Lalwani saying he changed his rating due to relative outperformance and said further upside might be limited from here. 5. Travelers (TRV) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Kai Pan saying lower reserve releases and rising auto claims present a risk to earnings and post US election share strength underestimates these fundamental headwinds. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
TSN Tyson Foods
$62.08

-1.02 (-1.62%)

02/07/17
JEFF
02/07/17
NO CHANGE
Target $75
JEFF
Buy
Tyson Foods price-fixing allegations unfounded, says Jefferies
Jefferies analyst Akshay Jagdale attributes yesterday's pullback in shares of Tyson Foods to concerns about the newly disclosed SEC investigation and ongoing worries about peaking margins. The SEC investigation represents a short-term overhang but Beef and Pork margins will eventually normalize, Jagdale tells investors in a post-earnings research note. The analyst believes the chicken price-fixing allegations are unfounded. He keeps a Buy rating on Tyson's with a $75 price target. The company's "value-added earnings stream remains significantly undervalued," Jagdale writes.
03/16/17
ARGS
03/16/17
DOWNGRADE
ARGS
Hold
Tyson Foods downgraded on probe, earnings outlook, bird flu at Argus
As noted earlier, Argus downgraded Tyson Foods to Hold from Buy. As reasons for the downgrade, analyst John Staszak cited the SEC probe of Tyson and other poultry producers, potential decelerating earnings in coming quarters, and a recent bird flu outbreak in two states.
03/16/17
ARGS
03/16/17
DOWNGRADE
ARGS
Hold
Tyson Foods downgraded to Hold from Buy at Argus
12/02/16
KEYB
12/02/16
INITIATION
KEYB
Overweight
Tyson Foods initiated at KeyBanc
As noted earlier, KeyBanc initiated Tyson Foods with a $70 price target and an Overweight rating. The firm says that concerns about the company are "overdone," while the shares have reached an attractive entry point. It thinks that the company's "significant branded momentum and solid free cash flow" should enable it to carry out share repurchases and potentially make acquisitions. The firm is upbeat on the company's outlook.
WSM Williams-Sonoma
$49.47

1.35 (2.81%)

03/13/17
FBCO
03/13/17
NO CHANGE
Target $44
FBCO
Neutral
Williams-Sonoma price target lowered to $44 from $50 at Credit Suisse
Credit Suisse analyst Seth Sigman lowered his price target for Williams-Sonoma to $44 from $50 ahead of Q4 results. Over the next year, the analyst believes that the combination of sluggish comps, incremental gross margin pressures from shipping and discounting, and higher investments will pressure EPS more than expected. He reiterates a Neutral rating on the shares.
03/16/17
WBLR
03/16/17
DOWNGRADE
WBLR
Market Perform
Williams-Sonoma downgraded to Market Perform from Outperform at William Blair
William Blair analyst Daniel Hofkin downgraded Williams-Sonoma to Market Perform following the company's Q4 results.
02/13/17
TLSY
02/13/17
DOWNGRADE
Target $51
TLSY
Market Perform
Williams-Sonoma downgraded to Market Perform at Telsey Advisory
As previously reported, Telsey Advisory downgraded Williams-Sonoma to Market Perform from Outperform, as analyst Cristina Fernandez said the company is fighting a more competitive environment and softer consumer spending by aggressively increasing promotions to maintain share. The analyst is surprised by the high level of promotions at West Elm and said some real estate contacts have noted softening store sales in December. The analyst, who also said the turnaround at Pottery Barn could take longer and sees limited margin expansion in 2017, decreased her price target on the stock to $51 from $61.
02/13/17
02/13/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Boeing (BA) downgraded to Underperform from Neutral at Buckingham with the firm saying at current levels, shares are priced for perfection and reflect optimistic free-cash-flow estimates. The firm's analyst expects Boeing shares to underperform on downward estimate revisions, a series of negative catalysts, and multiple compression. 2. Reynolds American (RAI) downgraded to Sector Perform from Outperform at RBC Capital. 3. Occidental Petroleum (OXY) downgraded to Neutral from Buy at Mizuho with analyst Timothy Rezvan citing valuation, muted dividend growth, and increasing unit expense trends. 4. AK Steel (AKS) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Evan Kurtz saying he is concerned about AK's exposure to electrical steel and heavy auto steel, which could prove to be headwinds this year. 5. Williams-Sonoma (WSM) downgraded to Market Perform from Outperform at Telsey Advisory with analyst Cristina Fernandez saying the company is fighting a more competitive environment and softer consumer spending by aggressively increasing promotions to maintain share. The analyst is surprised by the high level of promotions at West Elm and said some real estate contacts have noted softening store sales in December. Fernandez said the turnaround at Pottery Barn could take longer and sees limited margin expansion in 2017. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
INO Inovio
$6.87

0.26 (3.93%)

03/16/17
MAXM
03/16/17
UPGRADE
Target $10
MAXM
Buy
Inovio upgraded to Buy from Hold at Maxim
Maxim analyst Jason McCarthy upgraded Inovio to Buy from Hold and set a $10 price target on the stock, stating that it has multiple earlier stage programs moving forward with more significant data points coming in 2017 while it moves closer to its pivotal study in cervical dysplasia. He notes that his model assumes that VGX-3100 is commercialized in 2021 for cervical dysplasia.
11/07/16
AGIS
11/07/16
INITIATION
Target $12
AGIS
Buy
Inovio initiated with a Buy at Aegis
Aegis analyst Jason Wittes initiated Inovio with Buy and a $12 price target.
03/16/17
03/16/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Oracle (ORCL) was upgraded to Market Perform from Underperform at JMP Securities and to Overweight from Neutral at JPMorgan. 2. GoPro (GPRO) upgraded to Neutral from Sell at Citi with analyst Stanley Kovler saying the recent stabilization in revenue as well as the company's "significant" restructuring initiatives accelerate its path to profitability to 2017 from 2019. These developments should, at the very least, stave off the bear scenario for a few quarters, Kovler tells investors in a research note. He raised his price target for GoPro shares to $9 from $8. 2. TJX (TJX) upgraded to Conviction Buy from Buy at Goldman with analyst Matthew Fassler saying the company offers long-term secular growth along with near-term catalysts. The analyst expects TJX to grow market share at the expense of department stores. 4. Inovio (INO) upgraded to Buy from Hold at Maxim with analyst Jason McCarthy saying it has multiple earlier stage programs moving forward with more significant data points coming in 2017 while it moves closer to its pivotal study in cervical dysplasia. He notes that his model assumes that VGX-3100 is commercialized in 2021 for cervical dysplasia. 5. Quest Diagnostics (DGX) upgraded to Neutral from Underperform at BofA/Merrill. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/16/17
PIPR
03/16/17
DOWNGRADE
Target $9
PIPR
Neutral
Inovio downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Charles Duncan downgraded Inovio to Neutral saying a "lack of focus and advancement for any one program" poses execution risk to the broader platform, and to shareholders. The analyst lowered his price target for the shares to $9 from $13 following the company's Q4 results.

TODAY'S FREE FLY STORIES

WLDN

Willdan Group

$24.52

-0.46 (-1.84%)

11:55
11/24/17
11/24
11:55
11/24/17
11:55
Conference/Events
Willdan Group management to meet with Wedbush »

Meeting with President…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

WLH

William Lyon Homes

$29.55

-0.33 (-1.10%)

11:51
11/24/17
11/24
11:51
11/24/17
11:51
Conference/Events
William Lyon Homes management to meet with Wedbush »

Meeting with CFO Severn…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLDR

Builders FirstSource

$19.52

0.07 (0.36%)

11:49
11/24/17
11/24
11:49
11/24/17
11:49
Conference/Events
Builders FirstSource management to meet with Wedbush »

Meeting with CFO Jackson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FUN

Cedar Fair

$67.06

0.51 (0.77%)

11:47
11/24/17
11/24
11:47
11/24/17
11:47
Conference/Events
Cedar Fair management to meet with Wedbush »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

HOG

Harley-Davidson

$47.26

-0.42 (-0.88%)

, PII

Polaris Industries

$123.17

-0.41 (-0.33%)

11:43
11/24/17
11/24
11:43
11/24/17
11:43
Conference/Events
Wedbush leisure analyst holds an analyst/industry luncheon meeting »

Leisure Analyst Haridman…

HOG

Harley-Davidson

$47.26

-0.42 (-0.88%)

PII

Polaris Industries

$123.17

-0.41 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PEP

PepsiCo

$115.91

0.83 (0.72%)

11:40
11/24/17
11/24
11:40
11/24/17
11:40
Options
One week call buyers in Pepsico »

One week call buyers in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSANY

Nissan

$19.10

-0.07 (-0.37%)

11:36
11/24/17
11/24
11:36
11/24/17
11:36
Periodicals
Nissan plans to unveil new gasoline-fueled engine next week, Reuters says »

Nissan plans to keep…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

ECYT

Endocyte

$4.82

0.07 (1.47%)

, PGNX

Progenics

$5.59

0.06 (1.09%)

11:35
11/24/17
11/24
11:35
11/24/17
11:35
Conference/Events
Wedbush biotech analyst holds an analyst/industry conference call »

Biotech Analyst…

ECYT

Endocyte

$4.82

0.07 (1.47%)

PGNX

Progenics

$5.59

0.06 (1.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBI

CB&I

$15.46

-0.16 (-1.02%)

11:35
11/24/17
11/24
11:35
11/24/17
11:35
Options
CB&I put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

AAPL

Apple

$174.96

1.82 (1.05%)

11:20
11/24/17
11/24
11:20
11/24/17
11:20
Options
Active trading in Apple expiring options »

Active trading in Apple…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$102.78

0.04 (0.04%)

, VIAB

Viacom

$26.68

-0.58 (-2.13%)

11:19
11/24/17
11/24
11:19
11/24/17
11:19
Hot Stocks
Box Office Battle: 'Coco' looking to take top spot from 'Justice League' »

"Coco," the…

DIS

Disney

$102.78

0.04 (0.04%)

VIAB

Viacom

$26.68

-0.58 (-2.13%)

LGF.B

Lionsgate

$31.68

0.355 (1.13%)

SNE

Sony

$47.92

0.7 (1.48%)

LGF.A

Lionsgate

$33.31

0.33 (1.00%)

FOXA

21st Century Fox

$30.61

-0.27 (-0.87%)

FOX

21st Century Fox

$29.94

-0.16 (-0.53%)

CMCSK

Comcast

CMCSA

Comcast

$36.41

-0.01 (-0.03%)

TWX

Time Warner

$89.91

-0.1 (-0.11%)

VIA

Viacom

$32.90

-0.45 (-1.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

$NSD

NASDAQ Market Internals

11:17
11/24/17
11/24
11:17
11/24/17
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

11:16
11/24/17
11/24
11:16
11/24/17
11:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNC

GNC Holdings

$5.65

0.2 (3.67%)

11:15
11/24/17
11/24
11:15
11/24/17
11:15
Options
GNC Holdings put volume heavy and directionally bearish »

Bearish flow noted in GNC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OSTK

Overstock.com

$61.05

0.6 (0.99%)

11:05
11/24/17
11/24
11:05
11/24/17
11:05
Options
Overstock com call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

M

Macy's

$21.56

0.93 (4.51%)

10:50
11/24/17
11/24
10:50
11/24/17
10:50
Options
Macy's calls outpace puts 2:1 as shares see strength »

Macy's calls outpace…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

GM

General Motors

$44.37

0.075 (0.17%)

10:40
11/24/17
11/24
10:40
11/24/17
10:40
Options
10K GM Dec 44 calls sold at $1.20 »

10K GM Dec 44 calls sold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

  • 09

    Jan

  • 16

    Jan

M

Macy's

$21.57

0.9366 (4.54%)

10:38
11/24/17
11/24
10:38
11/24/17
10:38
Technical Analysis
Technical View: Macy's ticks top of downtrend resistance line »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

MSON

Misonix

$10.58

0.025 (0.24%)

10:36
11/24/17
11/24
10:36
11/24/17
10:36
Hot Stocks
Breaking Hot Stocks news story on Misonix »

South Africa Alpha…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCEHY

Tencent

$54.89

-1.01 (-1.81%)

, NTDOY

Nintendo

$50.55

0.72 (1.44%)

10:35
11/24/17
11/24
10:35
11/24/17
10:35
Periodicals
Tencent denies rumor of Nintendo gaming JV in China, Marbridge Daily says »

Tencent (TCEHY) has…

TCEHY

Tencent

$54.89

-1.01 (-1.81%)

NTDOY

Nintendo

$50.55

0.72 (1.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,175.50

19.08 (1.65%)

10:34
11/24/17
11/24
10:34
11/24/17
10:34
Periodicals
Amazon workers in Germany, Italy strike on Black Friday, TechCrunch reports »

Workers at Amazon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

UEPS

Net 1 UEPS

$12.28

2.16 (21.34%)

10:30
11/24/17
11/24
10:30
11/24/17
10:30
Options
Notable new position opened in Net 1 Ueps Tech as shares stumble »

Notable new position…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FORR

Forrester

$46.55

-0.15 (-0.32%)

10:25
11/24/17
11/24
10:25
11/24/17
10:25
Conference/Events
Forrester management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

  • 29

    Nov

  • 05

    Dec

MRO

Marathon Oil

$15.04

0.161 (1.08%)

10:25
11/24/17
11/24
10:25
11/24/17
10:25
Options
Marathon Oil call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

GRC

Gorman-Rupp

$32.18

-0.29 (-0.89%)

10:24
11/24/17
11/24
10:24
11/24/17
10:24
Conference/Events
Gorman-Rupp management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.